AI healthcare OS CureMD has recently launched an ai-native healthcare operating system named 11x, indicating a strategic shift toward AI-driven health IT solutions. This presents upsell opportunities for AI analytics, automation, and enterprise integration services to enhance the new platform.

EHR and Genomics Existing integration with Tempus for genomic testing within CureMD's EHR suggests a readiness to partner with data-intensive genomic and precision medicine vendors. Sales potential exists for expanded genomics workflows, data exchange middleware, and genomics-reporting features.

Practice Management CureMD recently published a guide on optimizing healthcare practice management, signaling emphasis on workflow optimization and PM efficiencies. Opportunities exist to offer complementary practice optimization tools, training services, or managed services to extend their PM capabilities.

Rapid Testing Platform Launched Rapid Testing Platform for COVID-19 in 2022, showing capability in rapid deployment health IT solutions. Potential to repurpose or extend for current public health testing workflows, mobile clinics, or infection surveillance integrations.

Financial Scale Reported revenue in the low single to mid single millions with a very lean workforce, indicating a growth-focused organization that may favor scalable, cost-efficient solutions such as cloud-native enablement, low-touch implementations, and subscription-based offerings, as well as partnerships to accelerate sales reach.